The companies Aktis Oncology, Alumis, and Parabilis Medicines bagged the biggest biotech funding rounds overall in January ...

Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi ...

Delve into the Amarin v. Hikma case in which the U.S. Supreme Court might settle the skinny label question once and for all.

UK biotech showed resilience in a tough 2025 for healthcare funding, suggesting investor interest could grow in 2026.

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Discover J&J’s pipeline strategy for 2026 as it it projects that its sales for the year will be between $100 billion and $101 ...

Italy’s biotech ecosystem might be slightly smaller and less visible than some other European hubs, but it is home to a growing number of companies advancing ambitious therapeutic programs. From gene ...

From Dupixent to Tezspire and verekitug, explore emerging sinusitis treatments and the race to improve chronic rhinosinusitis ...

Discover how AI is transforming biologics discovery, tackling adoption challenges, and driving growth in the biologics market.

Asking whether China is the future of the biotech industry might seem counterintuitive, considering the current biotech geopolitical context. If you haven’t followed this series of events, a ...

Based in Switzerland, Alentis Therapeutics is a clinical-stage biotech company developing first-in-class therapies that target Claudin-1 (CLDN1), a tight-junction protein abnormally expressed in ...

News & press releases monitoring: We closely monitor the latest news and press releases, ensuring we only feature investments that could have a real impact on the industry. Specialized databases: We ...